Intriguingly, within tumor specimens, PUS1 expression positively correlated with tumor grade, stage, and poor prognosis (Fig. 1H-M), providing compelling insights into its clinical relevance and prognostic potential in prostate cancer. Here, PUS1 is linked to prostate carcinoma.